1. Could Amgen’s latest bad news boost their interest in acquisitions? — Senators urge FTC to scrutinize pharma mega-mergers — Merck’s Keytruda combo wins simultaneous approvals in US, Canada, and Australia — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Thoughts on this company?

Discussion in 'Vision Sciences' started by Anonymous, Jul 6, 2012 at 4:56 PM.

  1. Anonymous

    Anonymous Guest

    This company seems interesting...any thoughts?
     
  2. Anonymous

    Anonymous Guest

    No strong leadership at the top. The CEO is in way over her head. Looks anorexic too.
     
  3. Anonymous

    Anonymous Guest

    My friend just left said no leadership and changed comp plan a few times in a year.
     
  4. Anonymous

    Anonymous Guest

    Isn't she from Stryker spine? how is the VP of Sales who was hired late last year?
     
  5. Anonymous

    Anonymous Guest

    She is and was way over her head there as well. Fits requirements for EEOC and that's about it. Don't know VP of sales. Seems almost irrelevant without strong leadership and good management at the top.
     
  6. Anonymous

    Anonymous Guest

    She hired some real fucktards to drive the business at Stryker. What a lousy leader she was and good riddens!
     
  7. Anonymous

    Anonymous Guest

    She is a fucktard! Haha!
     
  8. anonymous

    anonymous Guest

    Test test